Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CryptoMedix

CryptoMedix
2013 FOUNDED
PRIVATE STATUS
Debt LATEST DEAL TYPE
$514K LATEST DEAL AMOUNT
Description

Developer of a proprietary technology for cancer and certain inflammatory diseases. The company is focused on commercialization of a portfolio of biologics and diagnostic agents with potential for cancer and certain inflammatory diseases.

Formerly Known As
CryptoMedix LLC
Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Primary Industry
Biotechnology
Other Industries
Other Healthcare
Primary Office
  • 464 Basin Point Road
  • Harpswell, ME 04079
  • United States

+1 (207) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CryptoMedix’s full profile, request a free trial.

CryptoMedix Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Debt - General 08-Jun-2016 $514K 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

CryptoMedix Executive Team (4)

Name Title Board
Seat
Contact
Info
Janet Yancey-Wrona Ph.D Chief Operating Officer & Board Member
Bernd Seizinger Ph.D Co-Founder and Managing Director
Peter Brooks Ph.D Co-Founder & Chief Scientific Adviser
Leonard Liebes Ph.D Co-Founder, Board Member & Chief Operations Manager

CryptoMedix Board Members (4)

Name Representing Role Since Contact
Info
Bob Davis CryptoMedix Board Member 000 0000
Bob Suva CryptoMedix Board Member 000 0000
Janet Yancey-Wrona Ph.D CryptoMedix Chief Operating Officer & Board Member 000 0000
Leonard Liebes Ph.D CryptoMedix Co-Founder, Board Member & Chief Operations Manager 000 0000